Comparison of effect of intensive lipid lowering with atorvastatin to less intensive lowering with lovastatin on C-reactive protein in patients with stable angina pectoris and inducible myocardial ischemia.
Kinlay
Scott
S
Cardiovascular Division, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA. skinlay@partners.org
Timms
Tracy
T
Clark
Maureen
M
Karam
Carolina
C
Bilodeau
Tim
T
Ridker
Paul M
PM
Rifai
Nader
N
Carlson
William
W
Lloyd-Jones
Donald M
DM
Johnstone
Michael
M
Rubenstein
Joel
J
Alexander
Sidney
S
Orav
John
J
Stone
Peter H
PH
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000787:Angina Pectoris / Q000097:blood / Q000150:complications* / Q000188:drug therapy*; D000069059:Atorvastatin; D002097:C-Reactive Protein / Q000187:drug effects*; D008076:Cholesterol, HDL / Q000097:blood / Q000187:drug effects; D008078:Cholesterol, LDL / Q000097:blood / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D005500:Follow-Up Studies; D006538:Heptanoic Acids / Q000627:therapeutic use*; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D008148:Lovastatin / Q000627:therapeutic use*; D008875:Middle Aged; D017202:Myocardial Ischemia / Q000097:blood / Q000188:drug therapy* / Q000209:etiology*; D011758:Pyrroles / Q000627:therapeutic use*; D013997:Time Factors; D016896:Treatment Outcome; D014280:Triglycerides / Q000097:blood
D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D006538:Heptanoic Acids; D000960:Hypolipidemic Agents; D011758:Pyrroles; D014280:Triglycerides; D002097:C-Reactive Protein; D008148:Lovastatin; D000069059:Atorvastatin